Clinical Trials List
Protocol NumberBGB-HNSCC-201
Active
2023-07-01 - 2026-01-31
Phase II
Recruiting1
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 劉奕廷 無
- Shang-Yin Wu 無
- 顏志傑 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Min Liao 無
- 陳珈妤 無
- Ming-Yu Lien 無
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
160 participants
